- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer.
December 28, 2022
Female sexual function in bladder cancer: A review of the evidence.
December 28, 2022
Sex Remains Negative Prognostic Factor in Contemporary Cohort of High-Risk Non-Muscle-Invasive Bladder Cancer.
December 27, 2022
Clinical and economic impact of blue light cystoscopy in the management of NMIBC at US ambulatory surgical centers: what is the site-of-service disparity?
December 26, 2022
Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design.
December 26, 2022
The Role of Neoadjuvant Chemotherapy in Bladder Preservation Approaches in Muscle-Invasive Bladder Cancer.
December 23, 2022
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer.
December 23, 2022
New synthetic nano-immunotherapy (OncoTherad®) for non-muscle invasive bladder cancer: Its synthesis, characterization and anticancer property.
December 23, 2022
Bladder EpiCheck urine test in the follow-up of NMIBC: a cost analysis.
December 22, 2022
The Legacy of RTOG/NRG Protocols in Shaping Current Bladder Preservation Therapy in North America.
December 22, 2022
Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer.
December 22, 2022
Modeling PTEN and P53 Inactivation in Muscle-Invasive Bladder Cancer - Expert Commentary
December 21, 2022
Smoking cessation pharmacotherapy use during index hospital admission following cystectomy for bladder cancer: A retrospective cohort study.
December 21, 2022
Robotic-assisted Versus Laparoscopic Versus Open Radical Cystectomy-A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.
December 21, 2022
Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer.
December 21, 2022
